← Open Payments lookup

DANIEL GILLETTE: Open Payments

NPI 1053376475 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$44,115 in 82 payments from 13 companies in 2025. Trend: 2023 $708 · 2024 $999 · 2025 $44,115

Honoraria: $40,350Travel & lodging: $2,396Food & beverage: $1,369
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.50$29,898
MDD US Operations, LLC10$13,797
E.R. Squibb & Sons, L.L.C.3$89
Lundbeck LLC4$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$52
Teva Pharmaceuticals USA, Inc.2$33
Neurocrine BioSciences, Inc.2$33
Janssen Pharmaceuticals, Inc2$32
Otsuka America Pharmaceutical, Inc.2$30
Vanda Pharmaceuticals Inc.1$25

Products named: Qelbree, REXULTI, COBENFY, CAPLYTA, AUSTEDO XR, INGREZZA, HETLIOZ, ARISTADA.

Industry payments across IA — which companies pay providers there.